Skip to content

13D filed by SV Biotech Crossover Opportunities Fund LP

SV Biotech Crossover Opportunities Fund LP and 1 other reporting person reported 1,920,667 TRXB shares, 7% of the class, as of 2026-10-08, in a 13D accepted by EDGAR 2026-10-16 19:53:17 UTC.

Accession
0001829126-26-011242
Filer
CIK 1903934
Filed
2026-10-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Stake

Shares
1,920,667
Percent of class
7%
Event date
2026-10-08

How the shares relate across the reporting persons: every reporting person reports the same shares (a chain of control). The page shows the largest row.

Reporting persons

PersonTypeSole votingShared votingSole dispositiveShared dispositiveAggregatePercent
SV Biotech Crossover Opportunities Fund LPPN1,920,66701,920,66701,920,6677%
SV BCO I GP LLPPN1,920,66701,920,66701,920,6677%